Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cresco Labs (TSE:CL)
CNQX:CL
Cresco Labs (CL) Stock Price & Analysis
169 Followers
CL Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$1.35 - C$3.78
Previous CloseC$2.74
Volume37.34K
Average Volume (3M)344.97K
Market Cap
C$1.20B
Enterprise ValueC$1.88B
Total Cash (Recent Filing)$103.43M
Total Debt (Recent Filing)$682.76M
Price to Earnings (P/E)-3.8
Beta1.39
Next Earnings
May 15, 2024EPS Estimate
-C$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.72
Shares Outstanding480,292,624
10 Day Avg. Volume128,584
30 Day Avg. Volume344,971
Standard Deviation0.21
R-Squared0.20
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-14.10
Price to Sales (P/S)4.53
Price to Cash Flow (P/CF)-75.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.44
Enterprise Value/Gross Profit5.20
Enterprise Value/Ebitda-131.27
Forecast
1Y Price Target
C$7.58Price Target Upside184.87% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Cresco Labs News
PremiumCompany Announcements
Cresco Labs Achieves Solid Profitability in 2023
PremiumCompany Announcements
Cresco Labs Announces Upcoming Earnings Release
Bulls Say, Bears Say
Bulls Say
Earnings And Growth StrategyCresco Labs Inc. reported results that significantly beat forecasts, attributed to a successful 'Year of the Core' strategy focusing on profitable growth and strong adjusted EBITDA.
Market Expansion PotentialCresco Labs Inc. has potential for further upside growth surprises, with expectations of core medical markets pushing for adult-use cannabis sales legalization.
Operational EfficiencyThe Company's strategic investments in efficiency and cost optimizations have contributed to an impressive earnings beat and an 11% reduction in SG&A expenses.
Bears Say
Delayed Growth ResumptionManagement's 2024 outlook indicates a low-single-digit revenue decline in the short term before expecting growth resumption.
Revenue DeclineManagement’s 2024 outlook is mixed with an anticipated low-single-digit revenue decline in the near term, suggesting a softer organic growth outlook.
Weak Sales MomentumManagement expects revenues to be down by a mid-single-digit rate, with sales momentum appearing to drip lower, impacting 2024 forecasts.
---
Options Prices
Currently, No data available
---
Ownership Overview
58.72% Insiders
1.69% Mutual Funds
0.07% Other Institutional Investors
39.52% Public Companies and
Individual Investors
CL FAQ
What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was C$1.35 and its highest was C$3.78 in the past 12 months.
What is Cresco Labs’s market cap?
Currently, no data Available
When is Cresco Labs’s upcoming earnings report date?
Cresco Labs’s upcoming earnings report date is May 15, 2024 which is in 18 days.
How were Cresco Labs’s earnings last quarter?
Cresco Labs released its earnings results on Mar 13, 2024. The company reported C$0.014 earnings per share for the quarter, beating the consensus estimate of -C$0.033 by C$0.047.
Is Cresco Labs overvalued?
According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
Does Cresco Labs pay dividends?
Cresco Labs does not currently pay dividends.
What is Cresco Labs’s EPS estimate?
Cresco Labs’s EPS estimate is -C$0.03.
How many shares outstanding does Cresco Labs have?
Cresco Labs has 320,757,100 shares outstanding.
What happened to Cresco Labs’s price movement after its last earnings report?
Cresco Labs reported an EPS of C$0.014 in its last earnings report, beating expectations of -C$0.033. Following the earnings report the stock price went up 12.264%.
Which hedge fund is a major shareholder of Cresco Labs?
Currently, no hedge funds are holding shares in TSE:CL
---
Cresco Labs Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$7.58 (184.87% Upside)
C$7.58 (184.87% Upside)
Blogger Sentiment
Bullish
TSE:CL Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $2.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days <0.1%
Last 30 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.75%
12-Months-Change
Fundamentals
Return on Equity
-30.99%
Trailing 12-Months
Asset Growth
-14.22%
Trailing 12-Months
Company Description
Cresco Labs
Cresco Labs Inc is a Canada based company engaged in the production and sale of cannabis. The company distribute its products to dispensaries nationwide, including several dispensaries owned and operated by its team. Its product includes Reserve, Remedi, Mindy's. All the revenues of the company were generated in the United States. It has ownership interests in Illinois, Pennsylvania, Ohio, California, Maryland, and Arizona.
---
CL Company Deck
---
CL Earnings Call
Q4 2024
0:00 / 0:00
---
CL Stock 12 Months Forecast
Average Price Target
C$7.58
▲(184.87% Upside)
Technical Analysis
Cresco Labs
―
Green Thumb Industries
―
Curaleaf Holdings
―
Trulieve Cannabis
―
Supernus Pharmaceuticals
―
Best Analysts Covering CL
1 Year
1 Year Success Rate
9/23 ratings generated profit
1 Year Average Return
+15.56%
reiterated a buy rating 2 months ago
Copying Derek Dley's trades and holding each position for 1 Year would result in 39.13% of your transactions generating a profit, with an average return of +15.56% per trade.
---